Markets:

Overview

News

Currencies

International

Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

24.39 -1.59 (-6.12%)

Streaming Delayed Price Updated: 12:50 PM EST, Dec 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

99 100 Next >

Pfizer Advances On Its Cancer Journey ↗

September 20, 2024

On Saturday, Pfizer Inc (NYSE: PFE) presented positive trial data for experimental drug designed for patients suffering from cancer cachexia during the European Society for Medical Oncology 2024...

Via Benzinga

Down 13% in 1 Day, Is Moderna Stock in Trouble? ↗

September 20, 2024

There's no hope of it recovering to its prior heights anytime soon.

Via The Motley Fool

3 Beaten-Down Stocks Ready for a Comeback

September 19, 2024

if you're looking for a way to escape the market volatility, here are three stocks that are trading near their 52-week lows with solid catalysts for growth

Via MarketBeat

Topics Economy

Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks ↗

September 19, 2024

This strategic play will take time to pay off, but it could keep growth going.

Via The Motley Fool

Moderna, Inc. REMINDER – MRNA Stockholders Should Contact Robbins LLP for Information About the Moderna, Inc. Class Action and Pending Lead Plaintiff Deadline

September 18, 2024

From Robbins LLP

Via GlobeNewswire

16 Analysts Have This To Say About Moderna ↗

September 13, 2024

Via Benzinga

Here's How Much You Would Have Made Owning Moderna Stock In The Last 5 Years ↗

September 13, 2024

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

September 18, 2024

Via Benzinga

Jim Cramer Labels Moderna A 'Big Disappointment,' But Suggests Doubling Down On Another Pharma Powerhouse ↗

September 18, 2024

Jim Cramer likes Pfizer and recommends buying more stock. Six Flags is struggling, but Cramer likes First Solar and Equity Residential. Moderna has been disappointing, but Cramer likes Vertiv and...

Via Benzinga

Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 ↗

September 18, 2024

These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond.

Via The Motley Fool

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 17, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Tradepulse Power Inflow Alert: Moderna Inc. Rises 8.9% On The Trading Day ↗

September 13, 2024

Via Benzinga

S&P 500 Briefly Hits Record High Just Ahead Of Fed Rate Cut, Extends 7-Day Winning Streak: Tuesday's Top 5 Gainers ↗

September 17, 2024

S&P 500 hits new record highs amidst expectations for Fed interest rate decision. Small-cap stocks outperform, while uncertainty remains.

Via Benzinga

Topics Economy Stocks

Momentum Investing Gives You An Edge, Until It Doesn’t ↗

September 17, 2024

Since 2020, momentum investing has generated significantly better returns than other strategies. Such is not surprising, given the massive amounts of stimulus injected into the financial system.

Via Talk Markets

Small Caps, Bitcoin Rally As Traders Await Fed Rate Cut; Treasury Yields, US Dollar Tick Up On Strong Retail Sales: What's Driving Markets Tuesday? ↗

September 17, 2024

Wall Street experienced a slightly positive session Tuesday, supported by investor optimism as the Federal Open Market Committee (FOMC) kicked off its two-day meeting, expected to deliver the first...

Via Benzinga

Topics Economy

What's Going On With Moderna Shares Tuesday? ↗

September 17, 2024

Moderna shares are moving higher on Tuesday after the company announced that Health Canada approved its updated COVID-19 vaccine.

Via Benzinga

Moderna Receives Health Canada Approval For Updated COVID-19 Vaccine Targeting KP.2 Variant Of SARS-COV-2 For Ages Six Months And Older

September 17, 2024

Via ACCESSWIRE

MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline

September 16, 2024

From Bernstein Liebhard LLP

Via GlobeNewswire

DeSantis Administration Cautions Against Pfizer, Moderna mRNA Covid Vaccines for Vulnerable Individuals, Cites Concerns Related To Rare Heart Conditions ↗

September 16, 2024

Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration urges healthcare providers to prioritize alternative vaccines for seniors and...

Via Benzinga

Moderna’s Recent Drop: 4 Reasons Bulls See Opportunity

September 16, 2024

Moderna Inc. (NASDAQ: MRNA) made headlines during the pandemic for its messenger ribonucleic acid (mRNA) technology used in its COVID-19 vaccine Spikevax.

Via MarketBeat

Moderna, Tyson Foods And Adobe Are Among Top 10 Large Cap Stock Losers Last Week (Sep 8-Sep 14): Are The Others In Your Portfolio? ↗

September 15, 2024

10 worst performing large-cap stocks last week: RTO, ALLY, MRNA, HUM, TSN, BEKE, ADBE, RYAAY, JPM, DVN. Consider impact on your portfolio.

Via Benzinga

Down More Than 50%, Is It Time to Buy Moderna Stock as the Biotech Charts a New Post-COVID Path? ↗

September 15, 2024

This highflier has fallen on hard times recently.

Via The Motley Fool

Wall Street's Top 10 Stock Calls This Week - Saturday, Sept. 14 ↗

September 14, 2024

What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Sept. 9-13, 2024.

Via Talk Markets

Investing in Biotech or Pharma Stocks? Pay Attention to These 3 Things and You'll Win More ↗

September 14, 2024

Financial factors aren't the only things that are worth paying attention to.

Via The Motley Fool

After Moderna's Shocking News, Is the Stock a Buy or a Sell? ↗

September 14, 2024

Moderna held its annual R&D day this week.

Via The Motley Fool

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna, Lululemon, XPEL, and Nano Nuclear and Encourages Investors to Contact the Firm

September 13, 2024

From Bragar Eagel & Squire

Via GlobeNewswire

Moderna Faces Analyst Downgrades Amid Revised R&D Restructured Strategy and Delayed Profitability Target ↗

September 13, 2024

Moderna announces plans to reduce R&D spending by $1.1 billion by 2027, focusing on ten key products. Analysts highlight near-term challenges, lowered price targets, and a delayed breakeven to 2028,...

Via Benzinga

Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday ↗

September 13, 2024

Via Benzinga

Moderna's Pain Continues Amid Flurry Of Downgrades Following 'Tough' R&D Day ↗

September 13, 2024

The company offered a series of updates that shook shares on Thursday. The selloff continued on Friday.

Via Investor's Business Daily

Should You Buy Novavax Stock After This Regulatory Win? ↗

September 13, 2024

The biotech continues to earn important wins, but is it enough?

Via The Motley Fool

< Previous 1 2

...

22 23 24 25 26 27 28 29 30

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.